Bolt Biotherapeutics, Inc. (BOLT) Return on equity 2021–2025
Bolt Biotherapeutics, Inc. (BOLT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-125.9%FY2025 · since FY2021: -39.4% → -125.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -125.9% | -15.6 pp |
| FY2024 | -110.4% | -49.0 pp |
| FY2023 | -61.4% | -10.0 pp |
| FY2022 | -51.4% | -11.9 pp |
| FY2021 | -39.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Net marginBOLT Gross profitBOLT Gross marginBOLT Operating incomeBOLT Operating marginBOLT Operating cash flowBOLT Free cash flowBOLT Capital expendituresBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Total liabilitiesBOLT Shareholders’ equityBOLT overview →